Opaleye Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Opaleye Management's SMMT Position: Q3 2026 in Review
Opaleye Management opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 1,051,901 shares worth $17.8M. The stake represents 2% of the portfolio and ranks #16 among its holdings.
295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Opaleye Management held 1,051,901 shares of Summit Therapeutics worth $17.8M as of Q3 2026.
- Summit Therapeutics was a new Opaleye Management position in Q3 2026.
- Summit Therapeutics made up 2% of Opaleye Management's portfolio in Q3 2026, its #16 holding.
- 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Opaleye Management's 13F filing for Q3 2026, filed 16 Nov 2026.